The U.S. Food and Drug Administration has approved Journey Medical's drug for the treatment of a long-term skin condition ...

An international team of researchers have developed a promising new drug that could help combat the spread of ...

In a paper published in the Journal of Medicinal Chemistry, the researchers outline how the treatment could be more effective ...

Researchers created a bioelectronic device that reduces harmful bacterial behavior through electrical stimulation, ...

A new study sheds light on how the blood-borne parasite that causes African sleeping sickness in humans and related diseases in cattle and other animals establishes long-term infections in hosts.

A study, published in Molecular Psychiatry, led by Prof. Bernard Lerer from the Department of Psychiatry at the ...

A rare amoeba caused Brooklyn McCasland to go blind in one eye — and she’s still struggling with the parasitic infection ...

Malaria kills over 600,000 people a year, and as the climate warms, the potential range of the disease is growing. While some ...

They're ever-present, especially when it comes to skin infections," says Inclan-Rico, a postdoctoral researcher in the ...

As scientists learn more about a deadly parasite's ability to move from host to host in turkey flocks, a long-standing theory is in question and opens the door to new preventative measures.

Amphetamine- and methylphenidate-based drugs are the first-choice medications used for treating many people with attention deficit hyperactivity disorder (ADHD). They are available in a generic ...